MCID: SCL017
MIFTS: 38

Sclerosing Hemangioma

Categories: Cancer diseases, Cardiovascular diseases

Aliases & Classifications for Sclerosing Hemangioma

MalaCards integrated aliases for Sclerosing Hemangioma:

Name: Sclerosing Hemangioma 12 15 74
Cutaneous Fibrous Histiocytoma 74
Sclerosing Haemangioma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:495
SNOMED-CT 69 72079004

Summaries for Sclerosing Hemangioma

MalaCards based summary : Sclerosing Hemangioma, also known as cutaneous fibrous histiocytoma, is related to pulmonary sclerosing hemangioma and hemangioma of lung. An important gene associated with Sclerosing Hemangioma is NKX2-1 (NK2 Homeobox 1), and among its related pathways/superpathways is Neuroscience. The drugs Ifosfamide and Mechlorethamine have been mentioned in the context of this disorder. Affiliated tissues include skin, bone and endothelial, and related phenotype is behavior/neurological.

Wikipedia : 77 Benign fibrous histiocytomas are benign skin... more...

Related Diseases for Sclerosing Hemangioma

Diseases related to Sclerosing Hemangioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 239)
# Related Disease Score Top Affiliating Genes
1 pulmonary sclerosing hemangioma 32.8 CHGA CTNNB1 NKX2-1 SFTPB SYP
2 hemangioma of lung 30.6 NKX2-1 SFTPB
3 hemangioma 30.4 CHGA ENO2 NKX2-1 SFTPB SYP
4 cystadenocarcinoma 30.1 MUC1 PGR
5 cavernous hemangioma 29.8 MUC1 NKX2-1 SYP
6 papillary adenocarcinoma 29.8 MUC1 NKX2-1 PGR
7 carcinoid syndrome 29.4 CHGA ENO2 SYP
8 neuroendocrine tumor 29.1 CHGA ENO2 NKX2-1 SYP
9 mucinous bronchioloalveolar adenocarcinoma 10.4 MUC1 NKX2-1
10 adenosquamous carcinoma 10.4 MUC1 NKX2-1
11 signet ring cell adenocarcinoma 10.3 CHGA MUC1
12 gastric cardia carcinoma 10.3 CHGA MUC1
13 papilloma of choroid plexus 10.3 MUC1 SYP
14 oncocytoma 10.3 MUC1 SYP
15 rhabdoid tumor predisposition syndrome 1 10.3 MUC1 SYP
16 neurofibroma 10.3 MUC1 SYP
17 atypical choroid plexus papilloma 10.3 NKX2-1 SYP
18 solid adenocarcinoma with mucin production 10.3 MUC1 NKX2-1
19 meningioma, radiation-induced 10.3 MUC1 PGR
20 endocrine organ benign neoplasm 10.3 CHGA SYP
21 pneumothorax 10.3 MUC1 PGR
22 malignant ovarian surface epithelial-stromal neoplasm 10.3 MUC1 PGR
23 ovary epithelial cancer 10.3 MUC1 PGR
24 sertoli-leydig cell tumor 10.3 MUC1 PGR
25 mammary paget's disease 10.3 MUC1 PGR
26 pleomorphic xanthoastrocytoma 10.3 CHGA SYP
27 tanycytic ependymoma 10.3 CHGA SYP
28 non-functioning pancreatic endocrine tumor 10.3 CHGA SYP
29 pancreatic mucinous cystadenoma 10.3 MUC1 PGR
30 binswanger's disease 10.3 CHGA SYP
31 chickenpox 10.3 MUC1 PGR
32 mucinous adenocarcinoma 10.3 MUC1 NKX2-1
33 ureter small cell carcinoma 10.2 CHGA SYP
34 esophageal neuroendocrine tumor 10.2 CHGA SYP
35 ovarian large-cell neuroendocrine carcinoma 10.2 CHGA SYP
36 lobular neoplasia 10.2 CTNNB1 MUC1
37 spermatocele 10.2 PGR SYP
38 sex cord-gonadal stromal tumor 10.2 PGR SYP
39 breast mucoepidermoid carcinoma 10.2 MUC1 PGR
40 acinar cell cystadenocarcinoma 10.2 CHGA SYP
41 polymorphous low-grade adenocarcinoma 10.2 CTNNB1 MUC1
42 peritoneal serous adenocarcinoma 10.2 CHGA SYP
43 cellular ependymoma 10.2 CHGA SYP
44 breast scirrhous carcinoma 10.2 MUC1 PGR
45 primary hepatic neuroendocrine carcinoma 10.2 CHGA SYP
46 endosalpingiosis 10.2 MUC1 PGR
47 ovarian small cell carcinoma 10.2 MUC1 SYP
48 gastrointestinal neuroendocrine tumor 10.2 CHGA SYP
49 gastrointestinal system benign neoplasm 10.2 CHGA CTNNB1
50 chordoid glioma 10.2 MUC1 NKX2-1

Graphical network of the top 20 diseases related to Sclerosing Hemangioma:



Diseases related to Sclerosing Hemangioma

Symptoms & Phenotypes for Sclerosing Hemangioma

MGI Mouse Phenotypes related to Sclerosing Hemangioma:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.1 CTNNB1 ENO2 NKX2-1 PGR SFTPB SYP

Drugs & Therapeutics for Sclerosing Hemangioma

Drugs for Sclerosing Hemangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 107)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ifosfamide Approved Phase 3,Phase 2,Phase 1,Not Applicable 3778-73-2 3690
2
Mechlorethamine Approved, Investigational Phase 3,Phase 2,Phase 1,Not Applicable 51-75-2 4033
3
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1,Not Applicable 23214-92-8 31703
4
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
5
Dactinomycin Approved, Investigational Phase 3 50-76-0 457193 2019
6
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
7
Carboplatin Approved Phase 3 41575-94-4 38904 10339178 498142
8
Epirubicin Approved Phase 3 56420-45-2 41867
9
Cyclophosphamide Approved, Investigational Phase 3,Phase 2 6055-19-2, 50-18-0 2907
10
Lenograstim Approved, Investigational Phase 3,Phase 2 135968-09-1
11
Trabectedin Approved, Investigational Phase 2, Phase 3 114899-77-3 108150
12
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1,Not Applicable 31703
13
Isophosphamide mustard Phase 3,Phase 2,Phase 1,Not Applicable 0
14 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1,Not Applicable
15 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1,Not Applicable
16 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1,Not Applicable
17 Alkylating Agents Phase 3,Phase 2,Phase 1,Not Applicable
18 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1,Not Applicable
19 Immunologic Factors Phase 3,Phase 1,Phase 2
20 Anti-Infective Agents Phase 3,Phase 2,Phase 1
21 Antimitotic Agents Phase 3,Phase 2,Phase 1
22 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
23 Antineoplastic Agents, Phytogenic Phase 3,Phase 1,Phase 2
24 Antirheumatic Agents Phase 3,Phase 2,Phase 1
25 Etoposide phosphate Phase 3,Phase 2
26 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
27
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
28
Indinavir Approved Phase 2 150378-17-9 5362440
29
Parathyroid hormone Approved, Investigational Phase 2,Phase 1 9002-64-6
30
Temozolomide Approved, Investigational Phase 2 85622-93-1 5394
31
Sunitinib Approved, Investigational Phase 2 557795-19-4, 341031-54-7 5329102
32
Gemcitabine Approved Phase 2,Phase 1 95058-81-4 60750
33
Docetaxel Approved, Investigational Phase 2,Phase 1 114977-28-5 148124
34
Bevacizumab Approved, Investigational Phase 2 216974-75-3
35
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
36
Romidepsin Approved, Investigational Phase 2 128517-07-7 5352062
37
Paclitaxel Approved, Vet_approved Phase 1, Phase 2,Phase 2 33069-62-4 36314
38
Miconazole Approved, Investigational, Vet_approved Phase 1, Phase 2,Phase 2 22916-47-8 4189
39
Sirolimus Approved, Investigational Phase 1, Phase 2,Phase 2 53123-88-9 46835353 6436030 5284616
40
Everolimus Approved Phase 1, Phase 2,Phase 2 159351-69-6 6442177 70789204
41
Dasatinib Approved, Investigational Phase 2 302962-49-8 3062316
42
Pembrolizumab Approved Phase 1, Phase 2 1374853-91-4
43
nivolumab Approved Phase 2,Phase 1 946414-94-4
44
Ipilimumab Approved Phase 2 477202-00-9
45
Mesna Approved, Investigational Phase 2,Not Applicable 3375-50-6 598
46 Olaratumab Approved, Investigational Phase 2 1024603-93-7
47
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
48
Cisplatin Approved Phase 2 15663-27-1 441203 84093 2767
49
leucovorin Approved Phase 2 58-05-9 6006 143
50
Talimogene laherparepvec Approved, Experimental, Investigational Phase 2 1187560-31-1

Interventional clinical trials:

(show top 50) (show all 73)
# Name Status NCT ID Phase Drugs
1 Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Unknown status NCT00334854 Phase 3 doxorubicin hydrochloride;ifosfamide
2 Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma Unknown status NCT01344018 Phase 3
3 Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00002898 Phase 3 carboplatin;cyclophosphamide;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
4 Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00346164 Phase 3 doxorubicin hydrochloride;ifosfamide
5 Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma Completed NCT00423618 Phase 3
6 Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis Completed NCT00091351 Phase 3
7 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma Completed NCT00002764 Phase 3 doxorubicin hydrochloride;ifosfamide
8 Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00003212 Phase 3 doxorubicin hydrochloride;ifosfamide
9 Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00061984 Phase 3 doxorubicin hydrochloride;ifosfamide
10 Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00003052 Phase 3 doxorubicin hydrochloride;etoposide;ifosfamide
11 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00002641 Phase 3 doxorubicin hydrochloride;ifosfamide;isolated perfusion
12 Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Active, not recruiting NCT02180867 Phase 2, Phase 3 Doxorubicin Hydrochloride;Ifosfamide;Pazopanib Hydrochloride
13 Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Terminated NCT01189253 Phase 2, Phase 3 doxorubicin hydrochloride;trabectedin
14 Autologous Dendritic Cell Vaccine Loaded With Allogeneic Tumor Lysate Expression of Cancer Testis Antigens in Patients With Soft Tissue Sarcoma Unknown status NCT01883518 Phase 1, Phase 2
15 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2 indinavir sulfate;ritonavir
16 Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma Unknown status NCT00410462 Phase 2 brostallicin;doxorubicin hydrochloride
17 Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Unknown status NCT00003718 Phase 2 temozolomide
18 Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma Completed NCT00031915 Phase 2 imatinib mesylate
19 Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma Completed NCT00400569 Phase 2 Sunitinib Malate (SU011248)
20 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Completed NCT00474994 Phase 2 sunitinib malate
21 Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes Completed NCT00887809 Phase 2 gemcitabine;docetaxel;bevacizumab
22 Bevacizumab and Radiation Therapy for Sarcomas Completed NCT00356031 Phase 2 Bevacizumab
23 Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung Completed NCT00503295 Phase 2
24 AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00659360 Phase 2 saracatinib
25 Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma Completed NCT00245102 Phase 2 sorafenib tosylate
26 Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Completed NCT00112463 Phase 2 romidepsin
27 Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors Completed NCT01962103 Phase 1, Phase 2 nab-paclitaxel;nab-paclitaxel
28 Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma Completed NCT00085475 Phase 2 imatinib mesylate
29 Alisertib in Treating Patients With Advanced or Metastatic Sarcoma Completed NCT01653028 Phase 2 Alisertib
30 Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma Completed NCT00949325 Phase 1, Phase 2 temsirolimus plus liposomal doxorubicin
31 Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00064220 Phase 2 soblidotin
32 BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors Completed NCT00526149 Phase 2 BI 2536
33 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00003939 Phase 2 trabectedin
34 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma Completed NCT00006357 Phase 1, Phase 2 imatinib mesylate
35 Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma Completed NCT00053794 Phase 2 perifosine
36 Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00041249 Phase 2 brostallicin
37 Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00041236 Phase 2 exatecan mesylate
38 Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Completed NCT01154452 Phase 1, Phase 2 Gamma-Secretase Inhibitor RO4929097;Vismodegib
39 Trial of Dasatinib in Advanced Sarcomas Completed NCT00464620 Phase 2 Dasatinib
40 Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma Recruiting NCT03123276 Phase 1, Phase 2 Pembrolizumab;Gemcitabine
41 Study of Neoadjuvant Checkpoint Blockade in Patients With Surgically Resectable Undifferentiated Pleomorphic Sarcoma and Dedifferentiated Liposarcoma Recruiting NCT03307616 Phase 2 Nivolumab;Ipilimumab
42 Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma Recruiting NCT03190174 Phase 1, Phase 2 Nab-Rapamycin
43 Hypofractionated Radiotherapy With Sequential Chemotherapy in Primary Unresectable or Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall Recruiting NCT03651375 Phase 2 Sequential chemotherapy - 3 courses of AI
44 Doxorubicin With Upfront Dexrazoxane Plus Olaratumab for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma Recruiting NCT02584309 Phase 2 Dexrazoxane;Doxorubicin;Olaratumab
45 Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Recruiting NCT01532687 Phase 2 Gemcitabine Hydrochloride;Pazopanib Hydrochloride
46 A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma Active, not recruiting NCT00667342 Phase 2 Cisplatin;Doxorubicin;Methotrexate;Ifosfamide;etoposide
47 Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers Active, not recruiting NCT02392637 Phase 2 Abraxane (Nab-Paclitaxel);Cisplatin;Gemcitabine
48 Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma Active, not recruiting NCT02601209 Phase 1, Phase 2 Pazopanib Hydrochloride;Sapanisertib
49 A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas Not yet recruiting NCT03899805 Phase 2 Eribulin;Pembrolizumab
50 Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery Suspended NCT02923778 Phase 2

Search NIH Clinical Center for Sclerosing Hemangioma

Genetic Tests for Sclerosing Hemangioma

Anatomical Context for Sclerosing Hemangioma

MalaCards organs/tissues related to Sclerosing Hemangioma:

42
Skin, Bone, Endothelial, Lymph Node, Brain, Thyroid, Testis

Publications for Sclerosing Hemangioma

Articles related to Sclerosing Hemangioma:

(show top 50) (show all 168)
# Title Authors Year
1
<sup>18</sup>F-FDG PET/CT characteristics of pulmonary sclerosing hemangioma vs. pulmonary hamartoma. ( 29930720 )
2018
2
Hepatic Sclerosing Hemangioma with Predominance of the Sclerosed Area Mimicking a Biliary Cystadenocarcinoma. ( 30402303 )
2018
3
Hepatic Sclerosing Hemangioma Simulating Gallbladder Carcinoma: A Rare Case. ( 30564006 )
2018
4
Pneumocytoma (sclerosing hemangioma), a potential pitfall. ( 28398699 )
2017
5
Pulmonary sclerosing hemangioma with a rare symptom: A case report and review of the literature. ( 28357098 )
2017
6
Sclerosing hemangioma of the lung showing strong FDG avidity on PET scan: Case report and review of the current literature. ( 27222778 )
2016
7
Preoperative Diagnosis in 46 Cases of Pulmonary Sclerosing Hemangioma. ( 27231179 )
2016
8
Co-occurrence of bronchial papilloma and pulmonary sclerosing hemangioma in a male. ( 27812454 )
2016
9
Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung. ( 27601661 )
2016
10
Clinical case report: Sclerosing hemangioma of the liver, a rare but great mimicker. ( 27257450 )
2016
11
Pulmonary Hilar Tumor: An Unusual Presentation of Sclerosing Hemangioma. ( 27761142 )
2016
12
Sclerosing hemangioma: A diagnostic dilemma in fine needle aspiration cytology. ( 27168758 )
2016
13
Ectopic ACTH syndrome caused by pulmonary carcinoid tumor mimicking long-standing sclerosing hemangioma. ( 26828249 )
2016
14
Bone metastasis in pulmonary sclerosing hemangioma. ( 26552471 )
2015
15
Multiple hepatic sclerosing hemangioma mimicking metastatic liver tumor successfully treated by laparoscopic surgery: Report of a case. ( 25679307 )
2015
16
Incidental finding of a sclerosing hemangioma in a Caucasian woman. ( 26193226 )
2015
17
Sclerosing hemangioma of the lung. ( 26223076 )
2015
18
Sclerosing Hemangioma of the Lung Mimicking Pulmonary Metastasis. ( 25762452 )
2015
19
The significance of p40 expression in sclerosing hemangioma of lung. ( 25130377 )
2014
20
Pulmonary sclerosing hemangioma with lymph node metastasis: A case report and literature review. ( 24944657 )
2014
21
Pulmonary sclerosing hemangioma: a unique epithelial neoplasm of the lung (report of 26 cases). ( 23587094 )
2013
22
Diagnosis of sclerosing hemangioma of lung: don't rely on fine-needle aspiration cytology diagnosis alone. ( 24518736 )
2013
23
Unusual coexistence of pulmonary sclerosing hemangioma and pericardial cyst. ( 24887810 )
2013
24
Cytologic features of sclerosing hemangioma of the lung on crush preparations. ( 21710650 )
2013
25
A rare tumor of the lung: pulmonary sclerosing hemangioma (pneumocytoma). ( 23290153 )
2013
26
Histogenesis of pulmonary sclerosing hemangioma and significance of P63 expression. ( 23910931 )
2013
27
18F-FDG PET/CT features of pulmonary sclerosing hemangioma. ( 22291338 )
2013
28
A sclerosing hemangioma of the liver. ( 24459649 )
2013
29
Synchronous occurrence of breast cancer and pulmonary sclerosing hemangioma: management and review of the literature. ( 23838116 )
2013
30
Pneumocytoma (formerly known as sclerosing hemangioma of the lung): a rare cause of chest pain. ( 23380035 )
2013
31
Pulmonary sclerosing hemangioma presenting with dense spindle stroma cells: a potential diagnostic pitfall. ( 23227905 )
2012
32
A case of pulmonary sclerosing hemangioma with low (18)FDG uptake in PET. ( 22740968 )
2012
33
Treatment of 28 patients with sclerosing hemangioma (SH) of the lung. ( 22515818 )
2012
34
In pulmonary sclerosing hemangioma expression of I^-catenin, Axin, and C-myc differs between the two cell types. ( 22614067 )
2012
35
Fine-needle aspiration diagnosis of sclerosing hemangioma (pneumocytoma): Report of a case and review of the literature. ( 22645055 )
2012
36
Sclerosing hemangioma of the lung manifesting as a cystic lesion with an air-fluid level. ( 22832056 )
2012
37
Pulmonary sclerosing hemangioma: report of two cases. ( 22943472 )
2012
38
Pulmonary sclerosing hemangioma with pleural dissemination: report of a case. ( 21264765 )
2011
39
A case of sclerosing hemangioma forming a pedunculated mass. ( 21881332 )
2011
40
Sclerosing hemangioma in the liver. ( 22102394 )
2011
41
Determination of clonal status of pulmonary sclerosing hemangioma with X-chromosome inactivation mosaicism and polymorphism of phosphoglycerate kinase and androgen receptor genes. ( 20422318 )
2011
42
Coexistence of pulmonary sclerosing hemangioma and primary adenocarcinoma in the same nodule of lung. ( 21599956 )
2011
43
Pulmonary sclerosing hemangioma: pitfalls in management. ( 21471259 )
2011
44
Comparison of genetic and epigenetic alterations at 11 tumor suppressor loci in pulmonary sclerosing hemangioma and adenocarcinoma. ( 21649526 )
2011
45
A case of pulmonary sclerosing hemangioma surrounded by giant cystic change on high-resolution computed tomography. ( 20634757 )
2011
46
F-18 FDG PET/CT in evaluation of pulmonary sclerosing hemangioma. ( 21467848 )
2011
47
Microscopic sclerosing hemangioma diagnosed by histopathological examination after lung cancer surgery. ( 21881377 )
2011
48
Surgery for Pulmonary Sclerosing Hemangioma: Lobectomy versus Limited Resection. ( 22263122 )
2011
49
Pulmonary sclerosing hemangioma in a 21-year-old male with metastatic hereditary non-polyposis colorectal cancer: report of a case. ( 21645337 )
2011
50
Large masses with diffuse calcification: pulmonary sclerosing hemangioma. ( 20732478 )
2010

Variations for Sclerosing Hemangioma

Expression for Sclerosing Hemangioma

Search GEO for disease gene expression data for Sclerosing Hemangioma.

Pathways for Sclerosing Hemangioma

Pathways related to Sclerosing Hemangioma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.33 ENO2 NKX2-1 SYP

GO Terms for Sclerosing Hemangioma

Biological processes related to Sclerosing Hemangioma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of neuron death GO:1901215 8.96 CHGA CTNNB1
2 epithelial tube branching involved in lung morphogenesis GO:0060441 8.62 CTNNB1 NKX2-1

Sources for Sclerosing Hemangioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....